Actinium Pharmaceuticals ATNM
NYSE ATNM
$1.15 +0.01 (+0.88%)
As of: Sep 30, 2026 · 3:58 PM EDT

Actinium Pharmaceuticals (ATNM) EV to CFO (2022)

Updated

Actinium Pharmaceuticals' EV to CFO came in at 19.03 for Q4 2022, up 191.5% from the prior quarter.

Analysis

Actinium Pharmaceuticals (ATNM) EV to CFO (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Actinium Pharmaceuticals 35.84 Mn 35.84 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 19.03
Sep 30, 2022 6.53
Jun 30, 2022 0.29
API Access

Actinium Pharmaceuticals EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=ATNM&period=max&api_key=YOUR_API_KEY